ABT—An FDA advisory panel is voting today on the ABSORB bioabsorbable drug-eluting cardiac stent, which ABT is already selling in about 40 countries including those in the EU.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.